Results 131 to 140 of about 26,337 (144)

FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome

Neurology, 2001
To determine patterns of abnormalities on cerebral MRI that may characterize subgroups of patients with post-treatment Lyme disease syndrome (PTLDS) and to help identify pathomechanisms of disease.The authors analyzed the distribution of cerebral lesions in a cohort of 27 patients with PTLDS.
K, Morgen, R, Martin, R D, Stone, J, Grafman, N, Kadom, H F, McFarland, A, Marques   +6 more
openaire   +2 more sources

The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome

Journal of Clinical and Experimental Dermatology Research, 2016
Dapsone (diaminodiphenyl sulfone, i.e., DDS) is commonly used to treat dermatological conditions including acne, dermatitis herpetiformis, and leprosy. Mycobacterium leprae, a known "persister" bacteria, requires long-term treatment with intracellular medications including rifampin and Dapsone.
openaire   +1 more source

A distinct autoimmune signature in Post-treatment Lyme Disease Syndrome (PTLD)

The Journal of Immunology
Abstract Post-Treatment Lyme Disease (PTLD) is characterized as a persistent inflammatory condition in a large fraction of patients following antibiotic treatment for Borreliella infection, but what leads to PTLD is not known. Here, we analyzed 56 peripheral blood mononuclear cell (PBMC) samples from 23 individuals at risk for PTLD in a ...
Xin Chen, Xin Zhou, Haozhen Wang, Xuhuai Ji, Alison Rebman, Mark Soloski, Christine Wagner, Michael Snyder, William Robinson, John Aucott, Mark Davis   +10 more
openaire   +1 more source

Neuropsychological and Neuropsychiatric Functioning in Post-Treatment Lyme Disease

Abstract Lyme disease is a prevalent tick-borne infectious disease across temperate regions of the northern hemisphere. Chronic, persistent symptoms primarily characterized by fatigue, pain, and/or cognitive difficulties occur in a subgroup of individuals with Lyme disease even after receiving timely and appropriate treatment.
openaire   +1 more source

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease

Clinical Infectious Diseases, 2015
Donna McKenna, John Nowakowski, Carol Scavarda   +2 more
exaly  

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome

Clinical Immunology, 2011
Abhishek Chandra, Norman Latov, Gary P Wormser   +2 more
exaly  

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Quality of Life Research, 2012
John N Aucott, Lauren A Crowder
exaly  

Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2

Healthcare (Switzerland), 2018
Richard I Horowitz, Phyllis R Freeman
exaly  

Subjective Symptoms after Treatment of Early Lyme Disease

American Journal of Medicine, 2010
Tjaša Cerar, Eva Ruzic-Sabljic, Franc Strle   +2 more
exaly  

Treatment Trials for Post-Lyme Disease Symptoms Revisited

American Journal of Medicine, 2013
Mark S Klempner, Eugene D Shapiro, Adriana Marques   +2 more
exaly